Who We Are

The JPA Health Investor Relations (IR) practice brings together seasoned experts who transform complex science into compelling equity narratives that inspire engagement with the investment community and drive impact for patients.

We have deep experience developing and executing tailored IR solutions for clients at every stage of growth across the globe, and excel at translating corporate objectives into actionable strategies that accelerate their progress via the capital markets.

Our team integrates the right resources at the right time to ensure our clients stand out and succeed in today’s fast-paced market and digital landscape.

Why Choose JPA?

• Focused Expertise: Our IR professionals have served as trusted partners to private and public life sciences organizations at every stage from preclinical development through commercialization. We know how to engage investors, analysts and stakeholders with clarity, credibility and confidence.
• Strategic Storytelling: We translate groundbreaking science into compelling investment narratives. Our team excels at communicating your value proposition in a way that resonates with the investment community, driving attention, action and long-term relationships.
• Integrated Solutions: As part of a full-service health innovation agency, our IR team is seamlessly connected to JPA’s public relations, marketing, patient advocacy and medical communications practices. Our integrated approach ensures you receive access to synchronized support that amplifies your message across the right channels.
• Data-driven Insights: We harness advanced data analytics and AI-driven platforms to inform our strategies, delivering actionable insights that optimize your IR program and support informed decision-making.
• Global Reach, Personalized Service: With offices in the US and Europe and a growing international presence, we provide global perspective with boutique-level attention to detail and service. Our bespoke teams are built around your needs, ensuring agility and impact at every step.

Where We Excel

• IR Program Development and Management: We build and manage IR programs that align with your growth stage, strategic goals and investor audience. We develop tailored IR frameworks that include clear messaging platforms, disclosure strategies, investor targeting and calendar planning. And we provide guidance to ensure consistency, credibility and impact across all investor touchpoints to ensure that every engagement reinforces your equity story and builds long-term shareholder value.
• Equity Story and Messaging Strategy Refinement: We craft compelling equity stories that clearly articulate our clients’ value proposition, growth trajectory and market differentiation. Our specialists work closely with leadership teams to develop core messaging, Q&A documents and presentation materials that resonate with investors, analysts and other stakeholders.
• Investor Targeting and Outreach: Our team identifies and prioritizes investors who best match our clients’ profiles and strategic goals. Using advanced analytics and industry databases, we map the investor landscape, segment audiences and create targeted outreach campaigns. We facilitate introductions, manage meeting logistics and provide coaching to maximize engagement during roadshows, conferences and one-on-one meetings.
• Capital Markets Advisory: We offer expert guidance on capital markets transactions, including private rounds, IPOs, secondary offerings and private placements, by providing strategic counsel on timing, positioning and fit-for-purpose investor communications. Our experience spans all stages of development, helping clients navigate regulatory requirements and market expectations.
• Corporate Communications and Disclosure Strategy Support: We manage all aspects of corporate announcements, from drafting press releases and scripts to preparing investor presentations and conducting Q&A sessions. Our team ensures that messaging is aligned with corporate strategy and regulatory standards. Our IR experts advise and guide around special situations as well, including clinical trial setbacks, regulatory challenges or leadership transitions.
• Banking and Sell-side Engagement: We maintain deep relationships across the investment banking and sell-side research landscape, giving us unique insight into the individuals and institutions that are most integral to our clients’ success. From identifying the right analyst to connecting with new investment bankers and facilitating timely introductions, we ensure our clients are seen and heard by the right individuals at the right moment.